May 2011
World Federation of Societies of Biological Psychiatry, World Federation of Societies of Biological Psychiatry travel grant

2011
日本産業衛生学会, 優秀演題賞
杉田篤子

2010
日本精神神経学会, 若手国際学会派遣助成賞受賞
杉田篤子

2010
日本産業衛生学会, Best Good Practice award
Atsuko Ikenouchi-Sugita

2008
CINP, Rafaelsen Young Investigator Award
Atsuko Ikenouchi-Sugita

特集 心身相関-精神と身体の関係はどこまで解明されたか 【身体疾患における精神疾患･症状】 全身性エリテマトーデスに伴う神経精神症状
池ノ内 篤子
精神医学, Feb. 2026, Not reviewed, Invited
Lead, Corresponding

特集 昭和53年
池ノ内篤子
福岡県医報, Jan. 2026, Not reviewed, Invited
Lead

篤の中の小さな馬とともに
池ノ内篤子
北九州市医報, Jan. 2026, Not reviewed, Invited
Lead, Corresponding

Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in Schizophrenia
夏山 知也; Enkhmurun Chibaatar; 柴田 裕子; 岡本 直通; John Noel Cruz Victorino; 池ノ内 篤子; 柴田 智広; 吉村 玲児
九州神経精神医学, Dec. 2025, Not reviewed, Invited

Serum fetuin‐A in major depressive disorder: Lower levels in patients, but no correlation with symptom severity
Atsuko Ikenouchi; Rintaro Fujii; Reiji Yoshimura
Psychiatry and Clinical Neurosciences Reports, Sep. 2025, Reviewed, No invitation
Lead, Corresponding

Risk Factors in Japanese Drug Overdose Patients: Identifying Their Associations With Suicide Risk
Naomichi Okamoto; Atsuko Ikenouchi; Enkhmurun Chibaatar; Keita Watanabe; Ryohei Igata; Issei Seki; Reiji Yoshimura
OMEGA - Journal of Death and Dying, Sep. 2025, Reviewed, No invitation
Corresponding

Serum Lipidome Change in Japanese Patients with Major Depressive Disorder: A Real-World Exploratory Study
Naomichi Okamoto; Rintaro Fujii; Enkhmurun Chibaatar; Chihiro Iino; Atsuko Ikenouchi; Reiji Yoshimura
Neuropsychiatric Disease and Treatment, Aug. 2025, Reviewed, No invitation

気分症患者における復職促進および判断基準の均てん化にむけて—Toward Promotion of Return to Work and School Equalization of Decision Criteria in Patients with Mood Disorders
坪井 貴嗣; 佐渡 充洋; 吉村 玲児; 池ノ内 篤子; 渡辺 洋一郎; 井上 幸紀; 佐々木 達也
精神神経学雑誌 = Psychiatria et neurologia Japonica, May 2025, Not reviewed, Invited

Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in Schizophrenia
Tomoya Natsuyama; Enkhmurun Chibaatar; Yuko Shibata; Naomichi Okamoto; John Noel Cruz Victorino; Atsuko Ikenouchi; Tomohiro Shibata; Reiji Yoshimura
Neuropsychiatric Disease and Treatment, Apr. 2025, Reviewed, No invitation

Protocol for a Survey on the Impact of Caring for a Relative With Dementia on Caregivers’ Health and Work Functioning
IKENOUCHI Atsuko; FUJINO Yoshihisa; MATSUMOTO Tomomi; OKAMOTO Naomichi; HAMADA Shinsuke; KITAGAWA Shogo; MARUYAMA Shunya; KONISHI Yuki; EGUCHI Hisashi; YOSHIMURA Reiji
Journal of UOEH, Mar. 2025, Not reviewed, No invitation
Lead, Corresponding

Early detection and early response (secondary prevention) of mental disorders in the workplace—Perspectives for the post-covid era—
Iwasaki Shinichi; Hiro Hisanori; Deguchi Yasuhiko; Ikenouchi Atsuko; Mukai Keiichiro; Harada Tomoko; Matsushita Sachio
Japanese Journal of Occupational Mental Health, Feb. 2025, Not reviewed, Invited

Employment support for early-onset dementia
Ikenouchi Atsuko
Japanese Journal of Occupational Mental Health, Feb. 2025, Not reviewed, Invited
Lead, Corresponding

Hippocampal Sclerosis After Legionnaires' Disease: A Case Report.
Atsuko Ikenouchi; Satoru Ide; Gaku Hayasaki; Hiroaki Adachi; Reiji Yoshimura
Cureus, Dec. 2024

Cerebellar cognitive affective syndrome caused by cerebellar atrophy associated with Wallerian degeneration after pontine haemorrhage: a case report.
Atsuko Ikenouchi; Satoru Ide; Shinsuke Hamada; Reiji Yoshimura
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Sep. 2024

大量服薬自殺企図患者における危険因子の関連性 アソシエーションルール分析
岡本 直通; 池ノ内 篤子; チバータル・エンヘムルン; 渡邉 啓太; 井形 亮平; 関 一誠; 吉村 玲児
精神神経学雑誌, Jun. 2024

Human immunodeficiency virus-related neurocognitive disorder with hallucinations and delusions: A case report
Junpei Igata; Naomichi Okamoto; Hirofumi Tesen; Maya Akiyama; Satoru Ide; Atsuko Ikenouchi; Reiji Yoshimura
Psychiatry Research Case Reports, Jun. 2024

Volume enlargement of the choroid plexus and brain ventricles in drug-naïve, first-episode major depressive disorder.
Gaku Hayakawa; Enkmurun Chibaatar; Keita Watanabe; Naomichi Okamoto; Patrick M Quinn; Atsuko Ikenouchi; Takahiro Shinkai; Shingo Kakeda; Reiji Yoshimura
Journal of affective disorders, Mar. 2024

Fronto-striato network function is reduced in major depressive disorder.
Reoto Kijima; Keita Watanabe; Naomichi Okamoto; Atsuko Ikenouchi; Hirofumi Tesen; Shingo Kakeda; Reiji Yoshimura
Frontiers in psychiatry, 2024

A case of folate deficiency showing behavioural variant of frontotemporal dementia-like symptoms.
Arisa Fujii; Atsuko Ikenouchi; Naomichi Okamoto; Rintaro Fujii; Satoru Ide; Reiji Yoshimura
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Dec. 2023

Effect of risperidone on plasma vascular endothelial growth factor levels in patients with first-episode schizophrenia: A preliminary study
Reiji Yoshimura; Naomichi Okamoto; Gaku Hayasaki; Issei Seki; Reoto Kijima; Enkmurun Chibaatar; Atsuko Ikenouchi
Psychiatry Research Communications, Dec. 2023

Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus.
Naomichi Okamoto; Takashi Hoshikawa; Yuichi Honma; Enkhmurun Chibaatar; Atsuko Ikenouchi; Masaru Harada; Reiji Yoshimura
European archives of psychiatry and clinical neuroscience, Nov. 2023

Association between salivary mature brain-derived neurotrophic factor and psychological distress in healthcare workers.
Atsuko Ikenouchi; Naomichi Okamoto; Shinsuke Hamada; Enkhmurun Chibaatar; Rintaro Fujii; Yuki Konishi; Ryohei Igata; Hirofumi Tesen; Reiji Yoshimura
Brain and behavior, Oct. 2023

橋出血後のワーラー変性に伴う小脳萎縮により小脳性認知情動症候群が生じた1例
池ノ内 篤子; 北川 奨悟; 井手 智; 吉村 玲児
Dementia Japan, Oct. 2023

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study.
Issei Seki; Hiroto Izumi; Naomichi Okamoto; Atsuko Ikenouchi; Yasuo Morimoto; Seichi Horie; Reiji Yoshimura
International journal of molecular sciences, Sep. 2023

Triple network connectivity changes in patients with major depressive disorder versus healthy controls via structural network imaging after electroconvulsive therapy treatment.
Enkmurun Chibaatar; Keita Watanabe; Patrick M Quinn; Naomichi Okamoto; Takahiro Shinkai; Tomoya Natsuyama; Gaku Hayakawa; Atsuko Ikenouchi; Shingo Kakeda; Reiji Yoshimura
Journal of affective disorders, Aug. 2023

Auditory hallucinations of Buddhist chanting as an initial symptom of mild cognitive impairment with Lewy bodies.
Naomichi Okamoto; Atsuko Ikenouchi; Tatsuro Hirashima; Hirofumi Tesen; Satoru Ide; Reiji Yoshimura
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Jul. 2023

A Case of 10-Year Retrograde Amnesia, Cognitive Dysfunction, and Hippocampal Atrophy After Limbic Encephalitis Associated with Rickettsiosis
Naomichi Okamoto; Atsuko Ikenouchi; Shoichi Shimizu; Satoru Ide; Enkhmurun Chibaatar; Reiji Yoshimura
Psychiatry Research Case Reports, Jul. 2023

感染性辺縁系脳炎後に10年間の逆行性健忘と認知機能障害、海馬萎縮を呈した1例
岡本 直通; 池ノ内 篤子; 清水 少一; 井手 智; チバタール・エンヘムルン; 吉村 玲児
精神神経学雑誌, Jun. 2023

感染性辺縁系脳炎後に10年間の逆行性健忘と認知機能障害、海馬萎縮を呈した1例
岡本 直通; 池ノ内 篤子; 清水 少一; 井手 智; チバタール・エンヘムルン; 吉村 玲児
精神神経学雑誌, Jun. 2023

Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report.
Mako Yanaga; Naomichi Okamoto; Reia Hashimoto; Ryohei Igata; Yuki Konishi; Atsuko Ikenouchi; Naoki Isomoto; Takahiro Shinkai; Masaru Harada; Reiji Yoshimura
Journal of medical case reports, May 2023

A case of exploding head syndrome preceding the onset of mild cognitive impairment with Lewy bodies.
Shogo Kitagawa; Naomichi Okamoto; Atsuko Ikenouchi; Ryohei Igata; Reia Hashimoto; Yuki Konishi; Hirofumi Tesen; Reiji Yoshimura
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Mar. 2023

Prolonged delirium caused by lithium poisoning in an endometrial cancer patient at advanced stage: A case report.
Tomoya Natsuyama; Naomichi Okamoto; Haruka Akaji; Kaori Hoshino; Atsuko Ikenouchi; Reiji Yoshimura
Clinical case reports, Mar. 2023

Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
Yuya Fujita; Shigeru Iwata; Shinsuke Hidese; Sayuri Ishiwata; Satoru Ide; Hiroaki Tanaka; Koshiro Sonomoto; Yusuke Miyazaki; Shingo Nakayamada; Atsuko Ikenouchi; Kotaro Hattori; Hiroshi Kunugi; Reiji Yoshimura; Yoshiya Tanaka
Rheumatology, Feb. 2023

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression.
Reiji Yoshimura; Naomichi Okamoto; Enkmurun Chibaatar; Tomoya Natsuyama; Atsuko Ikenouchi
Biomedicines, Feb. 2023

Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory Study.
Naomichi Okamoto; Takashi Hoshikawa; Atsuko Ikenouchi; Tomoya Natsuyama; Rintaro Fujii; Ryohei Igata; Hirofumi Tesen; Yuki Konishi; Yuichi Honma; Masaru Harada; Reiji Yoshimura
Journal of integrative neuroscience, Jan. 2023

Duloxetine Does not Affect Vascular Endothelial Growth Factor Plasma Levels in Patients with First-Episode, Drug-Naïve Major Depression.
Reiji Yoshimura; Naomichi Okamoto; Atsuko Ikenouchi
Psychiatria Danubina, 2023

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression.
Atsuko Ikenouchi; Naomichi Okamoto; Tomomi Matsumoto; Reiji Yoshimura
Frontiers in psychology, 2023

A CASE OF PERSISTENT DEPRESSIVE DISORDER WITH A SIGNIFICANT RESPONSE TO THE ADDITION OF LURASIDONE TO VORTIOXETINE.
Reiji Yoshimura; Naomichi Okamoto; Shinsuke Hamada; Atsuko Ikenouchi
Psychiatria Danubina, 2023

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder.
Enkhmurun Chibaatar; Keita Watanabe; Naomichi Okamoto; Nasanbadrakh Orkhonselenge; Tomoya Natsuyama; Gaku Hayakawa; Atsuko Ikenouchi; Shingo Kakeda; Reiji Yoshimura
Frontiers in psychiatry, 2023

The effects of telecommuting and family cohabiting situation on psychological distress in Japanese workers during the COVID-19 pandemic: A cross-sectional study
Atsuko Ikenouchi; Yoshihisa Fujino; Ryutaro Matsugaki; Kosuke Mafune; Hajime Ando; Tomohisa Nagata; Seiichiro Tateishi; Reiji Yoshimura; Mayumi Tsuji
Journal of occupational health, Jan. 2023

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder.
Keita Watanabe; Naomichi Okamoto; Issei Ueda; Hirofumi Tesen; Rintaro Fujii; Atsuko Ikenouchi; Reiji Yoshimura; Shingo Kakeda
Brain communications, 2023

Isolated adrenocorticotropic hormone deficiency accompanied by impaired cognitive function: A case report
Atsuko Ikenouchi; Issei Seki; Naomichi Okamoto; Yuki Konishi; Reiji Yoshimura
Psychiatry Research Case Reports, Dec. 2022

Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression.
Reiji Yoshimura; Atsuko Ikenouchi; Naomichi Okamoto
Psychopharmacology bulletin, Oct. 2022

The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines.
Atsuko Ikenouchi; Naomichi Okamoto; Ryohei Igata; Tomoya Natsuyama; Reiji Yoshimura
Journal of integrative neuroscience, Jun. 2022

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study.
Naomichi Okamoto; Keita Watanabe; Hirofumi Tesen; Atsuko Ikenouchi; Ryohei Igata; Yuki Konishi; Tomoya Natsuyama; Rintaro Fujii; Shingo Kakeda; Taro Kishi; Nakao Iwata; Reiji Yoshimura
Neurology international, Apr. 2022

Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
Takashi Hoshikawa; Naomichi Okamoto; Tomoya Natsuyama; Rintaro Fujii; Atsuko Ikenouchi; Yuichi Honma; Masaru Harada; Reiji Yoshimura
Neuropsychiatric Disease and Treatment, Feb. 2022

Differences in the Disease Severity and Background Characteristics of Patients with Suicide Attempts Due to Overdose According to the Time of Day.
Tatsuro Hirashima; Naomichi Okamoto; Atsuko Ikenouchi; Toshihiko Mayumi; Reiji Yoshimura
Psychiatria Danubina, 2022

Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report.
Tetsuya Katsumura; Naomichi Okamoto; Hirofumi Tesen; Ryohei Igata; Atsuko Ikenouchi; Reiji Yoshimura
International medical case reports journal, 2022

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression.
Reiji Yoshimura; Naomichi Okamoto; Atsuko Ikenouchi
Therapeutic advances in psychopharmacology, 2022

Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major Depression.
Reiji- Yoshimura; Naomichi Okamoto; Atsuko Ikenouchi
Psychiatria Danubina, 2022

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram.
Reiji Yoshimura; Naomichi Okamoto; Ryohei Igata; Atsuko Ikenouchi
Alpha psychiatry, Jan. 2022

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms.
Tomoya Natsuyama; Naomichi Okamoto; Keita Watanabe; Enkhmurun Chibaatar; Hirofumi Tesen; Gaku Hayasaki; Atsuko Ikenouchi; Shingo Kakeda; Reiji Yoshimura
Frontiers in psychiatry, 2022

L-Arginine-Nitric Oxide Pathway and Neural Networks in Major Depression.
Naomichi Okamoto; Keita Watanabe; Atsuko Ikenouchi; Yukinori Korogi; Reiji Yoshimura
Psychiatria Danubina, 2022

Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls.
Rintaro Fujii; Keita Watanabe; Naomichi Okamoto; Tomoya Natsuyama; Hirofumi Tesen; Ryohei Igata; Yuki Konishi; Atsuko Ikenouchi; Shingo Kakeda; Reiji Yoshimura
Frontiers in molecular neuroscience, 2022

Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study.
Atsuko Ikenouchi; Yusuke Konno; Yoshihisa Fujino; Naoto Adachi; Yukihisa Kubota; Takaharu Azekawa; Hitoshi Ueda; Koji Edagawa; Eiichi Katsumoto; Eiichiro Goto; Seiji Hongo; Masaki Kato; Takashi Tsuboi; Norio Yasui-Furukori; Atsuo Nakagawa; Toshiaki Kikuchi; Koichiro Watanabe; Reiji Yoshimura
Neuropsychiatric disease and treatment, 2022

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report.
Naomichi Okamoto; Atsuko Ikenouchi; Satoru Ide; Yu Hashimoto; Reiji Yoshimura
Cerebellum (London, England), Oct. 2021

Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
Ryohei Igata; Hirofumi Tesen; Yuki Konishi; Atsuko Ikenouchi; Naomichi Okamoto; Reiji Yoshimura
Schizophrenia research, Jul. 2021

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid.
Naomichi Okamoto; Atsuko Ikenouchi; Issei Seki; Natsumi Hirano; Reiji Yoshimura
Cureus, Jul. 2021

Vortioxetine Improved Depressive State In Parkinson's Disease.
Reiji Yoshimura; Atsuko Ikenouchi; Naomichi Okamoto; Yuki Konishi
Cureus, Jun. 2021

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram.
Masamitsu Toshida; Yuki Konishi; Atsuko Ikenouchi; Naomichi Okamoto; Reiji Yoshimura
Cureus, May 2021

Major depression with musical obsession treated with vortioxetine: a case report.
Reiji Yoshimura; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi
Annals of general psychiatry, Mar. 2021

Vortioxetine improved olfactory reference syndrome in a patient with major depressive disorder: A case report
Reiji Yoshimura; Yuki Konishi; Naomichi Okamoto; Atsuko Ikenouchi
ARCHIVES OF CLINICAL PSYCHIATRY, Mar. 2021

A male case of frontotemporal lobar degeneration with behavioural and psychiatric symptoms responding to a low dose of escitalopram.
Atsuko Ikenouchi; Issei Seki; Kei Takaoka; Naomichi Okamoto; Sayuri Murakami; Reiji Yoshimura
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Mar. 2021

Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression.
Hirofumi Tesen; Keita Watanabe; Naomichi Okamoto; Atsuko Ikenouchi; Ryohei Igata; Yuki Konishi; Shingo Kakeda; Reiji Yoshimura
Frontiers in human neuroscience, 2021

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia.
Naomichi Okamoto; Atsuko Ikenouchi; Keita Watanabe; Ryohei Igata; Rintaro Fujii; Reiji Yoshimura
Frontiers in psychiatry, 2021

Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project.
Yusuke Konno; Yoshihisa Fujino; Atsuko Ikenouchi; Naoto Adachi; Yukihisa Kubota; Takaharu Azekawa; Hitoshi Ueda; Koji Edagawa; Eiichi Katsumoto; Eiichiro Goto; Seiji Hongo; Masaki Kato; Takashi Tsuboi; Norio Yasui-Furukori; Atsuo Nakagawa; Toshiaki Kikuchi; Koichiro Watanabe; Reiji Yoshimura
Neuropsychiatric disease and treatment, 2021

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine.
Reiji Yoshimura; Atsuko Ikenouchi; Naomichi Okamoto; Yuki Konishi
International medical case reports journal, 2021

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression.
Reiji Yoshimura; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi
Therapeutic advances in psychopharmacology, 2021

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study.
Naomichi Okamoto; Tomoya Natsuyama; Ryohei Igata; Yuki Konishi; Hirofumi Tesen; Atsuko Ikenouchi; Reiji Yoshimura
Frontiers in psychiatry, 2021

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings.
Naomichi Okamoto; Koji Yoshino; Shogo Kitagawa; Rintaro Fujii; Shinsuke Hamada; Atsuko Ikenouchi; Yuki Konishi; Nobuhisa Ueda; Yoshinori Eto; Yasunari Tsutsumi; Reiji Yoshimura
Frontiers in psychiatry, 2021

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report.
Naomichi Okamoto; Yuki Konishi; Hirofumi Tesen; Atsuko Ikenouchi; Reiji Yoshimura
International medical case reports journal, 2021

Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study.
LeHoa Nguyen; Shingo Kakeda; Keita Watanabe; Asuka Katsuki; Koichiro Sugimoto; Natsuki Igata; Takahiro Shinkai; Osamu Abe; Yukunori Korogi; Atsuko Ikenouchi; Reiji Yoshimura
Scientific reports, Dec. 2020

The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains.
Issei Ueda; Kazuhiro Takemoto; Keita Watanabe; Koichiro Sugimoto; Atsuko Ikenouchi; Shingo Kakeda; Asuka Katsuki; Reiji Yoshimura; Yukunori Korogi
PeerJ, Aug. 2020, Reviewed, No invitation

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder.
Asuka Katsuki; Keita Watanabe; LeHoa Nguyen; Yuka Otsuka; Ryohei Igata; Atsuko Ikenouchi; Shingo Kakeda; Yukunori Korogi; Reiji Yoshimura
International journal of molecular sciences, Apr. 2020

Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression
Yoshimura Reiji; Okamoto Naomichi; Konishi Yuki; Ikenouchi Atsuko
Clinical Neuropsychopharmacology and Therapeutics, 2020

Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia
Yoshimura Reiji; Ikenouchi Atsuko; Konishi Yuki
Clinical Neuropsychopharmacology and Therapeutics, 2020

A refractory case of a male patient with neuropsychiatric systemic lupus erythematosus with various psychiatric symptoms and MRI observations
Hashimoto Reia; Katsuki Asuka; Fujita Yuya; Ikenouchi Atsuko; Tanaka Yoshiya; Yoshimura Reiji
Clinical Neuropsychopharmacology and Therapeutics, 2020

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study.
Naomichi Okamoto; Keita Watanabe; LeHoa Ngyuyen; Atsuko Ikenouchi; Taro Kishi; Nakao Iwata; Shingo Kakeda; Yukunori Korogi; Reiji Yoshimura
Neuropsychiatric disease and treatment, 2020

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine.
Reiji Yoshimura; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi
Case reports in psychiatry, 2020

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression.
Masashi Ueda; Yuki Konishi; Kohei Sakurai; Atsuko Ikenouchi; Reiji Yoshimura
Case reports in psychiatry, 2020

Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13.
Kazunari Sugita; Can Altunbulakli; Hideaki Morita; Atsuko Sugita; Terufumi Kubo; Ryoko Kimura; Hiroyuki Goto; Osamu Yamamoto; Beate Rückert; Mübeccel Akdis; Cezmi A Akdis
Allergy, Dec. 2019

Does subjective sleep quality improve by a walking intervention? A real-world study in a Japanese workplace.
Hikaru Hori; Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Jun Nakamura
BMJ open, Oct. 2016, Reviewed, No invitation

Relationship Between Depressive State and Treatment Characteristics of Acute Cervical Spinal Cord Injury in Japan.
Yasufumi Matsuda; Tatsuhiko Kubo; Yoshihisa Fujino; Shinya Matsuda; Futoshi Wada; Atsuko Sugita
Journal of epidemiology, 2016, Reviewed, No invitation

[Niacin deficiency and cutaneous immunity].
Atsuko Ikenouchi-Sugita; Kazunari Sugita
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2015

Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder.
Reiji Yoshimura; Hikaru Hori; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Kiyokazu Atake; Jun Nakamura
Therapeutic advances in psychopharmacology, Jun. 2014, Reviewed, No invitation

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder.
Kiyokazu Atake; Reiji Yoshimura; Hikaru Hori; Asuka Katsuki; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Jun Nakamura
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2014, Reviewed, No invitation

No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.
Taro Kishi; Yasuhisa Fukuo; Masatsugu Moriwaki; Nakao Iwata; Hikaru Hori; Reiji Yoshimura; Asuka Katsuki; Atsuko Ikenouchi-Sugita; Kiyokazu Atake; Wakako Umene-Nakano; Jun Nakamura; Yasuhiro Kaneda; Kiyoshi Fujita
Psychiatry research, Mar. 2014, Reviewed, No invitation

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.
Reiji Yoshimura; Taro Kishi; Hikaru Hori; Asuka Katsuki; Atsuko Sugita-Ikenouchi; Wakako Umene-Nakano; Kiyokazu Atake; Nakao Iwata; Jun Nakamura
Psychiatry investigation, Jan. 2014

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naive major depressive disorder: a diffusion tensor imaging study
Kenji Hayashi; Reiji Yoshimura; Shingo Kakeda; Taro Kishi; Osamu Abe; Wakako Umene-Nakano; Asuka Katsuki; Hikaru Hori; Atsuko Ikenouchi-Sugita; Keita Watanabe; Satoru Ide; Issei Ueda; Junji Moriya; Nakao Iwata; Yukunori Korogi; Marek Kubicki; Jun Nakamura
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, Reviewed, No invitation

Abnormal white matter integrity in the corpus callosum among smokers: tract-based spatial statistics.
Wakako Umene-Nakano; Reiji Yoshimura; Shingo Kakeda; Keita Watanabe; Kenji Hayashi; Joji Nishimura; Hidehiko Takahashi; Junji Moriya; Satoru Ide; Issei Ueda; Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Kiyokazu Atake; Osamu Abe; Yukunori Korogi; Jun Nakamura
PloS one, 2014, Reviewed, No invitation

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study.
Kenji Hayashi; Reiji Yoshimura; Shingo Kakeda; Taro Kishi; Osamu Abe; Wakako Umene-Nakano; Asuka Katsuki; Hikaru Hori; Atsuko Ikenouchi-Sugita; Keita Watanabe; Satoru Ide; Issei Ueda; Junji Moriya; Nakao Iwata; Yukunori Korogi; Marek Kubicki; Jun Nakamura
Neuropsychiatric disease and treatment, 2014, Reviewed, No invitation

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.
Reiji Yoshimura; Taro Kishi; Hikaru Hori; Kiyokazu Atake; Asuka Katsuki; Wakako Nakano-Umene; Atsuko Ikenouchi-Sugita; Nakao Iwata; Jun Nakamura
Annals of general psychiatry, 2014, Reviewed, No invitation

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients.
Hikaru Hori; Reiji Yoshimura; Asuka Katsuki; Atsuko-Ikenouchi Sugita; Kiyokazu Atake; Jun Nakamura
Journal of psychiatric research, Dec. 2013

Current smoking rate in patients with psychiatric disorders in Japan: questionnaire survey.
Wakako Umene-Nakano; Reiji Yoshimura; Tsutomu Hoshuyama; Chiharu Yoshii; Kenji Hayashi; Hideki Nakano; Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Kiyokazu Atake; Jun Nakamura
Psychiatry research, Nov. 2013, Reviewed, No invitation

Prostaglandin E₂ is critical for the development of niacin-deficiency-induced photosensitivity via ROS production.
Kazunari Sugita; Atsuko Ikenouchi-Sugita; Yasuko Nakayama; Haruna Yoshioka; Takashi Nomura; Jun-Ichi Sakabe; Kyoko Nakahigashi; Etsushi Kuroda; Satoshi Uematsu; Jun Nakamura; Shizuo Akira; Motonobu Nakamura; Shuh Narumiya; Yoshiki Miyachi; Yoshiki Tokura; Kenji Kabashima
Scientific reports, Oct. 2013

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Reiji Yoshimura; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Asuka Katsuki; Kiyokazu Atake; Jun Nakamura
Human psychopharmacology, Sep. 2013, Reviewed, No invitation

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.
Yuki Tokutsu; Wakako Umene-Nakano; Takahiro Shinkai; Reiji Yoshimura; Tatsuya Okamoto; Asuka Katsuki; Hikaru Hori; Atsuko Ikenouchi-Sugita; Kenji Hayashi; Kiyokazu Atake; Jun Nakamura
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2013, Reviewed, No invitation

健康な勤労者におけるウォーキングの抑うつおよび社会適応の改善効果(The Effects of a Walking Intervention on Depressive Feelings and Social Adaptation in Healthy Workers)
杉田 篤子; 吉村 玲児; 杉田 和成; 堀 輝; 山田 久美; 坂上 真弓; 中村 純
産業医科大学雑誌, Mar. 2013, Reviewed, No invitation

Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Hikaru Hori; Wakako Umene-Nakano; Asuka Katsuki; Kazuyoshi Saito; Yoshiya Tanaka; Jun Nakamura
Human psychopharmacology, Mar. 2013, Reviewed, No invitation

Serum brain-derived neurotrophic factor levels at 6 months after remission are not associated with subsequent depressive episodes.
Reiji Yoshimura; Hikaru Hori; Atsuko Sugita-Ikenouchi; Wakako Umene-Nakano; Asuka Katsuki; Jun Nakamura
Journal of clinical psychopharmacology, Feb. 2013

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Reiji Yoshimura; Taro Kishi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Wakako Umene-Nakano; Nakao Iwata; Jun Nakamura
Progress in neuro-psychopharmacology & biological psychiatry, Dec. 2012, Reviewed, No invitation

帯状疱疹に関連した遠心性環状紅斑の1例(Erythema Annulare Centrifugum Associated with Herpes Zoster)
大森 俊; 杉田 和成; 杉田 篤子; 中村 元信
産業医科大学雑誌, Sep. 2012, Reviewed, No invitation

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
Asuka Katsuki; Reiji Yoshimura; Taro Kishi; Hikaru Hori; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Kenji Hayashi; Kiyokazu Atake; Nakao Iwata; Jun Nakamura
CNS spectrums, Sep. 2012, Reviewed, No invitation

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients.
Reiji Yoshimura; Taro Kishi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Asuka Katsuki; Kenji Hayashi; Nakao Iwata; Jun Nakamura
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2012, Reviewed, No invitation

Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline
Wakako Umene-Nakano; Reiji Yoshimura; Chiharu Yoshii; Kenji Hayashi; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Hikaru Hori; Jun Nakamura
NICOTINE & TOBACCO RESEARCH, Apr. 2012, Reviewed, No invitation

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
Journal of psychiatric research, Mar. 2012, Reviewed, No invitation

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.
Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Joji Nishimura; Junji Moriya; Kenji Hayashi; Asuka Katsuki; Hikaru Hori; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Yukunori Korogi; Jun Nakamura
Neuropsychiatric disease and treatment, 2012, Reviewed, No invitation

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Hayashi K; Atake K; Tomita M; Nakamura J
Human psychopharmacology, Jan. 2012, Reviewed, No invitation

Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
International journal of psychiatry in clinical practice, Dec. 2011, Reviewed, No invitation

Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self-evaluation Scale as calibrated using the Beck Depression Inventory.
Ueda N; Suda A; Nakagawa M; Nakano H; Umene-Nakano W; Ikenouchi-Sugita A; Hori H; Yoshimura R; Nakamura J
Psychiatry and clinical neurosciences, Dec. 2011, Reviewed, No invitation

Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Taro Kishi; Wakako Umene-Nakano; Hikaru Hori; Kenji Hayashi; Asuka Katsuki; Nobuhisa Ueda; Nakao Iwata; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Oct. 2011, Reviewed, No invitation

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients
Reiji Yoshimura; Taro Kishi; Akihito Suzuki; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Hikaru Hori; Koichi Otani; Nakao Iwata; Jun Nakamura
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Jun. 2011, Reviewed, No invitation

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Taro Kishi; Wakako Umene-Nakano; Hikaru Hori; Asuka Katsuki; Kazuyoshi Saito; Nakao Iwata; Yoshiya Tanaka; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Jun. 2011, Reviewed, No invitation

Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan
Kanae Okuno; Reiji Yoshimura; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Hikaru Hori; Kenji Hayashi; Asuka Katsuki; Hsin-I Chen; Jun Nakamura
PSYCHIATRY RESEARCH, Apr. 2011, Reviewed, No invitation

Effect of treatment with atypical drugs for 6 months on brain levels of N-acetyl aspartate or serum levels of brain-derived neurotrophic factor in early-stage first-episode schizophrenia - a preliminary study
Goto Naoki; Katsuki Asuka; Atake Kiyokazu; Korogi Yukunori; Nakamura Jun; Yoshimura Reiji; Kakeda Shingo; Nishimura Joji; Moriya Junji; Hayashi Kenji; Hori Hikaru; Ikenouchi-Sugita Atsuko; Umene-Nakano Wakako
Clinical Neuropsychopharmacology and Therapeutics, 2011

A case of discontinuation syndrome following the discontinuation of low-dose mirtazapine therapy in malignant lymphoma
Ikenouchi-Sugita Atsuko; Yoshimura Reiji; Nakamura Jun
Clinical Neuropsychopharmacology and Therapeutics, 2011

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
Wakako Umene-Nakano; Reiji Yoshimura; Nobuhisa Ueda; Akihito Suzuki; Atsuko Ikenouchi-Sugita; Hikaru Hori; Koichi Otani; Jun Nakamura
JOURNAL OF PSYCHOPHARMACOLOGY, Dec. 2010, Reviewed, No invitation

No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia
Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Junji Moriya; Hikaru Hori; Kenji Hayashi; Atsuko Ikenouchi-Sugita; Wakako Nakano-Umene; Asuka Katsuki; Joji Nishimura; Yukunori Korogi; Jun Nakamura
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Dec. 2010, Reviewed, No invitation

Brain-derived neurotrophic factor (BDNF) and mood disorder
Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Asuka Katsuki; Kenji Hayashi; Kiyokazu Atake; Nobuhisa Ueda; Jun Nakamura
Japanese Journal of Neuropsychopharmacology, Nov. 2010, Reviewed, No invitation

Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls
Reiji Yoshimura; Wakako Umene-Nakano; Tsutomu Hoshuyama; Atsuko Ikenouchi-Sugita; Hikaru Hori; Asuka Katsuki; Kenji Hayashi; Kiyokazu Atake; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Nov. 2010, Reviewed, No invitation

A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers.
Reiji Yoshimura; Atsuko Sugita-Ikenouchi; Hikaru Hori; Wakako Umene-Nakano; Kenji Hayashi; Asuka Katsuki; Nobuhisa Ueda; Jun Nakamura
International journal of psychiatry in clinical practice, Sep. 2010

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations
Reiji Yoshimura; Wakako Umene-Nakano; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Hikaru Hori; Asuka Katsuki; Kenji Hayashi; Kyoko Miyamoto; Yuki Kodama; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Aug. 2010, Reviewed, No invitation

Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study
Naoki Goto; Reiji Yoshimura; Junji Moriya; Shingo Kakeda; Kenji Hayashi; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Norihiro Oonari; Yukunori Korogi; Jun Nakamura
PSYCHIATRY RESEARCH-NEUROIMAGING, Apr. 2010, Reviewed, No invitation

Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study.
Goto N; Yoshimura R; Moriya J; Kakeda S; Hayashi K; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Oonari N; Korogi Y; Nakamura J
Psychiatry research, Apr. 2010, Reviewed, No invitation

Varenicline does not increase serum BDNF levels in patients with nicotine dependence
Wakako Umene-Nakano; Reiji Yoshimura; Chiharu Yoshii; Tsutomu Hoshuyama; Kenji Hayashi; Hikaru Hori; Asuka Katsuki; Atsuko Ikenouchi-Sugita; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Apr. 2010, Reviewed, No invitation

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression
Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Asuka Katsuki; Kenji Hayashi; Nobuhisa Ueda; Jun Nakamura
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Mar. 2010, Reviewed, No invitation

Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Tatsuya Okamoto; Wakako Umene-Nakano; Nobuhisa Ueda; Hikaru Hori; Asuka Katsuki; Kazuyoshi Saito; Yoshiya Tanaka; Jun Nakamura
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, Mar. 2010, Reviewed, No invitation

Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
Yuichiro Nakano; Reiji Yoshimura; Hideki Nakano; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Nobuhisa Ueda; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Mar. 2010, Reviewed, No invitation

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients
Reiji Yoshimura; Nobuhisa Ueda; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Jun Nakamura
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, Mar. 2010, Reviewed, No invitation

Inducible Nitric Oxide Synthase Downmodulates Contact Hypersensitivity by Suppressing Dendritic Cell Migration and Survival
Kazunari Sugita; Kenji Kabashima; Ryutaro Yoshiki; Atsuko Ikenouchi-Sugita; Masato Tsutsui; Jun Nakamura; Nobuyuki Yanagihara; Yoshiki Tokura
JOURNAL OF INVESTIGATIVE DERMATOLOGY, Feb. 2010, Reviewed, No invitation

Nonadherence to Paroxetine A Study Based on Monitoring Plasma Paroxetine Levels
Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Hikaru Hori; Nobuhisa Ueda; Jun Nakamura
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, Feb. 2010, Reviewed, No invitation

[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].
Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Hayashi K; Katsuki A; Ueda N; Nakamura J
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2010, Reviewed, No invitation

Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex
Atsuko Ikenouchi-Sugita; Yumiko Toyohira; Reiji Yoshimura; Susumu Ueno; Masato Tsutsui; Jun Nakamura; Nobuyuki Yanagihara
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, Dec. 2009, Reviewed, No invitation

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia
Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Junji Moriya; Kenji Hayashi; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Hikaru Hori; Nobuhisa Ueda; Yukunori Korogi; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Dec. 2009, Reviewed, No invitation

Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: Comparison between milnacipran and paroxetine
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Hikaru Hori; Wakako Umene-Nakano; Nobuhisa Ueda; Jun Nakamura
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Nov. 2009, Reviewed, No invitation

Trichotilliomania responding to low-dose fluvoxamine.
Ikenouchi-Sugita A; Yoshimura R; Ueda N; Nakamura J
Psychiatry and clinical neurosciences, Oct. 2009, Reviewed, No invitation

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients
Reiji Yoshimura; Wakako Umene-Nakano; Akihito Suzuki; Nobuhisa Ueda; Kyoko Miyamoto; Atsuko Ikenouchi-Sugita; Hikaru Hori; Koichi Otani; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Aug. 2009, Reviewed, No invitation

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study
Naoki Goto; Reiji Yoshimura; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Kenji Hayashi; Jun Nakamura; Junji Moriya; Shingo Kakeda; Norihiro Oonari; Yukunori Korog
SCHIZOPHRENIA RESEARCH, Jul. 2009, Reviewed, No invitation

Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence
Wakako Umene-Nakano; Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Kenji Hayashi; Nobuhisa Ueda; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Jul. 2009, Reviewed, No invitation

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Nobuhisa Ueda; Jun Nakamura
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Jun. 2009, Reviewed, No invitation

Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's chorea.
Wakako Umene; Reiji Yoshimura; Hikaru Hori; Hideki Nakano; Atsuko Sugita; Masayuki Shimono; Kenchi Takano; Naoki Shiota; Yoshinori Tomoda; Yukunori Korogi; Jun Nakamura
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Reviewed, No invitation

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
Hikaru Hori; Reiji Yoshimura; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Jun Nakamura
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, Reviewed, No invitation

Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers
Nobuhisa Ueda; Reiji Yoshimura; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Hikaru Hori Kenji Hayashi; Yuki Kodama; Jun Nakamura
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, Reviewed, No invitation

A case of late-onset Tourette's disorder successfully treated with aripiprazole: View from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Kenji Hayashi; Nobuhisa Ueda; Wakako Umene-Nakano; Hikaru Hori; Jun Nakamura
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, Reviewed, No invitation

Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline
Reiji Yoshimura; Wakako Umene-Nakano; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Hikaru Hori; Jun Nakamura
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Dec. 2008, Reviewed, No invitation

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes.
Ikenouchi-Sugita A; Yoshimura R; Ueda N; Kodama Y; Umene-Nakano W; Nakamura J
Neuropsychiatric disease and treatment, Dec. 2008, Reviewed, No invitation

Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study
Tatsuya Okamoto; Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Yoshiaki Inoue; Nobuhisa Ueda; Jun Nakamura
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Jul. 2008, Reviewed, No invitation

Two cases of burning mouth syndrome treated with olanzapine.
Nobuhisa Ueda; Yuki Kodama; Hikaru Hori; Wakako Umene; Atsuko Sugita; Hideki Nakano; Reiji Yoshimura; Jun Nakamura
Psychiatry and clinical neurosciences, Jun. 2008, Reviewed, No invitation

Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.
Reiji Yoshimura; Shingo Kakihara; Wakako Umene-Nakano; Atsuko Sugita; Hikaru Hori; Nobuhisa Ueda; Jun Nakamura
Human psychopharmacology, Jun. 2008, Reviewed, No invitation

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?
Masae Mitoma; Reiji Yoshimura; Atsuko Sugita; Wakako Umene; Hikaru Hori; Hideki Nakano; Nobuhisa Ueda; Jun Nakamura
Progress in neuro-psychopharmacology & biological psychiatry, Apr. 2008, Reviewed, No invitation

Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients.
Kyoko Miyamoto; Reiji Yoshimura; Nobuhisa Ueda; Atsuko Sugita; Wakako Umene; Hikaru Hori; Masae Mitoma; Jun Nakamura
Human psychopharmacology, Oct. 2007, Reviewed, No invitation

[Review of pharmacological efficacies and side effects of antidepressants].
Ikenouchi-Sugita A; Yoshimura R; Nakamura J
Nihon rinsho. Japanese journal of clinical medicine, Sep. 2007, Reviewed, No invitation

Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa
Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Hikaru Hori; Nobuhisa Ueda; Jun Nakamura
PSYCHIATRY AND CLINICAL NEUROSCIENCES, Aug. 2007, Reviewed, No invitation

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Reiji Yoshimura; Hikaru Hori; Atsuko Sugita; Nobuhisa Ueda; Shingo Kakihara; Wakako Umene; Yuichiro Nakano; Koji Shinkai; Masae Mitoma; Makiko Ohta; Takahiro Shinkai; Jun Nakamura
Progress in neuro-psychopharmacology & biological psychiatry, Jun. 2007, Reviewed, No invitation

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.
Reiji Yoshimura; Masae Mitoma; Atsuko Sugita; Hikaru Hori; Tatsuya Okamoto; Wakako Umene; Nobuhisa Ueda; Jun Nakamura
Progress in neuro-psychopharmacology & biological psychiatry, Jun. 2007, Reviewed, No invitation

Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.
Hikaru Hori; Reiji Yoshimura; Yasuhisa Yamada; Atsuko Ikenouchi; Masae Mitoma; Yoshishige Ida; Jun Nakamura
International clinical psychopharmacology, Jan. 2007, Reviewed, No invitation

Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
Reiji Yoshimura; Yuichiro Nakano; Hikaru Hori; Atsuko Ikenouchi; Nobuhisa Ueda; Jun Nakamura
Human psychopharmacology, Oct. 2006, Reviewed, No invitation

Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report.
Atsuko Ikenouchi; Reiji Yoshimura; Naomi Ikemura; Kensuke Utsunomiya; Masae Mitoma; Jun Nakamura
Progress in neuro-psychopharmacology & biological psychiatry, Sep. 2006, Reviewed, No invitation

A male case of monosymptomomatic hypochondriacal psychosis responding to olanzapine
A Ikenouchi; T Terao; J Nakamura
PHARMACOPSYCHIATRY, Sep. 2004, Reviewed, No invitation

Survey of nasal colonization by, and assessment of a novel multiplex PCR method for detection of biofilm-forming methicillin-resistant staphylococci in healthy medical students
H Miyamoto; K Imamura; A Kojima; H Takenaka; N Hara; A Ikenouchi; T Tanabe; H Taniguchi
JOURNAL OF HOSPITAL INFECTION, Mar. 2003, Reviewed, No invitation

【アルコールと内科疾患】　アルコールと薬物　アルコールと向精神物質の使用
池ノ内 篤子, 吉村 玲児, 中村 純
Medicina, Sep. 2005, Null, Null

健康の広場　認知症を予防するには～認知症対策は働く世代から始めましょう！～
池ノ内篤子
UOEH NEWS, Feb. 2021, Not reviewed, Invited
Lead, Corresponding

健康の広場　レビー小体型認知症
池ノ内篤子
UOEH NEWS, Dec. 2023, Not reviewed, Invited
Lead, Corresponding

一酸化窒素と精神疾患：うつ病と認知症との関連を中心に
池ノ内篤子, 吉村玲児
九州神経精神医学, Aug. 2020, Reviewed, No invitation
Lead

ＮＯと精神障害との関連　予備的研究報告
中野雄一郎、吉村玲児、池ノ内篤子、堀輝、中野英樹、中田靖、筒井正人、柳原延章、中村純
九州神経精神医学, Dec. 2006, Null, Null

研修会から　認知症疾患医療センターの役割と連携　産業医科大学病院認知症センターかかりつけ医研修会（令和3年11月17日）より
池ノ内　篤子、
北九州市医報, Feb. 2022, Not reviewed, Invited
Lead

双極性障害の安定性と就労～MUSUBI研究より～
池ノ内篤子
北九州市医報, Jun. 2022, Not reviewed, Invited
Lead, Corresponding

アルコール依存症を伴うdouble depressionにパロキセチンが有効であった1症例　血中catecholamine,BDNF,cytokines動態からの検討
吉村 玲児, 池ノ内 篤子, 堀 輝, 中村 純
日本アルコール精神医学雑誌, Apr. 2006, Null, Null

【うつ病における栄養・運動の役割】 勤労者における運動療法の可能性　うつ病の予防から治療、社会復帰まで
堀 輝, 杉田 篤子, 香月 あすか, 吉村 玲児, 中村 純
日本生物学的精神医学会誌, Mar. 2015, Null, Null

【睡眠障害の診断と治療】　うつ病の不眠の診断と治療
吉村 玲児, 堀 輝, 池ノ内 篤子, 中村 純
最新精神医学, Sep. 2006, Null, Null

【第二世代抗精神病薬の時代における精神医療】　第二世代抗精神病薬の新剤型と適応拡大　リスペリドンとオランザピンを中心に
吉村 玲児, 堀 輝, 池ノ内 篤子, 中村 純
最新精神医学, Jan. 2006, Null, Null
Last

ウィーキングの介入が自覚的睡眠を改善するのか？職場における実績的研究
堀輝、杉田篤子、吉村玲児、中村純、
産業医科大学雑誌, Mar. 2018, Null, Null

職場における精神疾患の早期発見，早期対応（二次予防）について～ポストコロナに向けた着眼点～
池ノ内篤子
産業精神保健, Feb. 2025, Not reviewed, Invited
Lead, Corresponding

若年性認知症の就労支援
池ノ内篤子
産業精神保健, Feb. 2025, Not reviewed, Invited
Lead, Corresponding

CORoNaWork　COVID-19流行時の在宅勤務と同居状況が労働者の心理的苦痛に及ぼす影響
池ノ内 篤子, 藤野 善久, 松垣 竜太郎, 真船 浩介, 安藤 肇, 永田 智久, 立石 清一郎, 吉村 玲児, 辻 真弓
産業衛生学雑誌, Apr. 2023, Not reviewed, Invited
Lead, Corresponding

うつ病患者でのＳＳＲＩ/ＳＮＲＩが血中ＢＤＮＦ、ＮＯｘ濃度におよぼす影響
吉村玲児、池ノ内篤子、堀輝、中田康、筒井正人、中島康秀、柳原延章、中村純、
神経化学, Aug. 2006, Null, Null

統合失調症患者に対する抗精神病薬誘発性体重増加に対するウォーキングの効果
堀輝, 杉田篤子, 吉村玲児, 中村純,
精神神経学, Jun. 2017, Null, Null

気分症患者における復職促進および判断基準の均てん化にむけて
吉村玲児, 坪井貴嗣, 佐渡充洋, 池ノ内篤子, 渡辺洋一郎, 佐々木達也, 井上幸紀
精神神経学雑誌, May 2025, Not reviewed, Invited

【精神疾患の悪化と間違えやすい身体の問題】SLEほか自己免疫疾患
池ノ内 篤子, 吉村 玲児
精神科, Dec. 2021, Not reviewed, Invited
Lead, Corresponding

妊娠後期の統合失調感情障害合併妊婦に修正型電気けいれん療法を施行し経腟分娩した1例
藤井 倫太郎, 古澤 隆太朗, 小西 勇輝, 池ノ内 篤子, 新開 隆弘, 吉村 玲児
精神科, Aug. 2021, Reviewed, Invited

【今日の精神科治療ハンドブック】(第15章)コンサルテーション・リエゾン(二次性の精神および行動の症候群を含む)　膠原病に伴う精神障害
池ノ内 篤子, 吉村 玲児
精神科治療学, Oct. 2021, Not reviewed, Invited
Lead, Corresponding

ノルアドレナリントランスポーター(NAT)遺伝子多型は非定型抗精神病薬の反応性を規定するか?
吉村 玲児, 新開 隆弘, 堀 輝, 池ノ内 篤子, 新開 浩二, 上田 展久, 三苫 正恵, 松本 知万, 中村 純
精神薬療研究年報, Mar. 2006, Null, Null

【老年期精神神経疾患と神経炎症】老年期うつ病と炎症　インターロイキン-6(IL-6)を中心に
星川 大, 小西 勇輝, 池ノ内 篤子, 吉村 玲児
老年精神医学雑誌, Jul. 2020, Not reviewed, Invited

【治療抵抗性,治療不耐性症例への対応】治療困難であった単一症状性心気精神病の3症例
井上 賀晶, 小嶋 秀幹, 後藤 牧子, 中野 雄一郎, 池ノ内 篤子, 中村 純
臨床精神薬理, Apr. 2005, Null, Null

臨床に役立つ基礎薬理学の用語解説(第41回)　Amyloid-related imaging abnormalities
池ノ内 篤子
臨床精神薬理, Mar. 2023, Not reviewed, Invited
Lead, Corresponding

臨床に役立つ基礎薬理学の用語解説(第33回)　脳アミロイドアンギオパチー
池ノ内 篤子
臨床精神薬理, Jul. 2022, Not reviewed, Invited
Lead, Corresponding

臨床に役立つ基礎薬理学の用語解説(第10回)　オピオイド受容体
池ノ内 篤子, 吉村 玲児
臨床精神薬理, Aug. 2020, Not reviewed, Invited
Lead

【プライマリーケアでよく診る精神疾患】各種精神症状・疾患への対応　うつ病・双極性障害-診断と治療
吉村 玲児, 小西 勇輝, 池ノ内 篤子
臨牀と研究, Sep. 2020, Reviewed, Invited
Last

Factors Influencing Continuing Employment Among Patients With Mood Disorders
Hirofumi Tesen, Tomomi Matsumoto, Maiko Umezu, Kenta Ide, Koji Yoshino, Ryohei Igata, Yuki Konishi, Naomichi Okamoto, Atsuko Ikenouchi, Yoshihisa Fujino, and Reiji Yoshimura
ASEAN Journal of Psychiatry, Aug. 2022, Reviewed, No invitation

SERUM LEVELS OF INTERLEUKIN-6 ,BRAIN-DERIVED NEUROTROPHIC FACTOR AND RETURN TO WORK IN PATIENTS WITH MAJOR DEPRESSION:PRELIMINARY STUDY
Reiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
ASEAN Journal of Psychiatry, Oct. 2021, Reviewed, No invitation
Last

Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13.
Sugita Kazunari, Altunbulakli Can, Morita Hideaki, Sugita Atsuko, Kubo Terufumi, Kimura Ryoko, Goto Hiroyuki, Yamamoto Osamu, Rückert Beate, Akdis Mübeccel, Akdis Cezmi A
Allergy, Dec. 2019, Null, Null

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram.
Yoshimura Reiji, Okamoto Naomichi, Igata Ryohei, Ikenouchi Atsuko
Alpha psychiatry, Jan. 2022, Reviewed, No invitation
Last

Major depression with musical obsession treated with vortioxetine: a case report.
Yoshimura Reiji, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko
Annals of general psychiatry, Mar. 2021, Reviewed, No invitation
Last

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.
Yoshimura Reiji, Kishi Taro, Hori Hikaru, Atake Kiyokazu, Katsuki Asuka, Nakano-Umene Wakako, Ikenouchi-Sugita Atsuko, Iwata Nakao, Nakamura Jun
Annals of general psychiatry, Jun. 2014, Reviewed, Null

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder - RETRACTION.
Ikenouchi Atsuko, Okamoto Naomichi, Konno Yusuke, Fujii Rintaro, Fujino Yoshihisa, Yoshimura Reiji
BJPsych open, Mar. 2022, Reviewed, No invitation
Lead, Corresponding

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder.
Ikenouchi Atsuko, Okamoto Naomichi, Konno Yusuke, Fujii Rintaro, Fujino Yoshihisa, Yoshimura Reiji
BJPsych open, Dec. 2021, Reviewed, No invitation
Lead

Does subjective sleep quality improve by a walking intervention? A real-world study in a Japanese workplace.
Hori Hikaru, Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Nakamura Jun
BMJ open, Oct. 2016, Reviewed, No invitation

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression.
Yoshimura Reiji, Okamoto Naomichi, Chibaatar Enkmurun, Natsuyama Tomoya, Ikenouchi Atsuko
Biomedicines, Feb. 2023, Reviewed, No invitation
Last

Association between salivary mature brain-derived neurotrophic factor and psychological distress in healthcare workers.
Ikenouchi Atsuko, Okamoto Naomichi, Hamada Shinsuke, Chibaatar Enkhmurun, Fujii Rintaro, Konishi Yuki, Igata Ryohei, Tesen Hirofumi, Yoshimura Reiji
Brain and behavior, Oct. 2023, Reviewed, No invitation
Lead, Corresponding

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder.
Watanabe Keita, Okamoto Naomichi, Ueda Issei, Tesen Hirofumi, Fujii Rintaro, Ikenouchi Atsuko, Yoshimura Reiji, Kakeda Shingo
Brain communications, Jan. 2023, Reviewed, No invitation

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
Katsuki Asuka, Yoshimura Reiji, Kishi Taro, Hori Hikaru, Umene-Nakano Wakako, Ikenouchi-Sugita Atsuko, Hayashi Kenji, Atake Kiyokazu, Iwata Nakao, Nakamura Jun
CNS spectrums, Sep. 2012, Reviewed, Null

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine.
Yoshimura Reiji, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko
Case reports in psychiatry, Oct. 2020, Not reviewed, No invitation
Last

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression.
Ueda Masashi, Konishi Yuki, Sakurai Kohei, Ikenouchi Atsuko, Yoshimura Reiji
Case reports in psychiatry, Dec. 2020, Reviewed, No invitation

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report.
Okamoto Naomichi, Ikenouchi Atsuko, Ide Satoru, Hashimoto Yu, Yoshimura Reiji
Cerebellum (London, England), Oct. 2021, Reviewed, No invitation
Corresponding

Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression
Reiji Yoshimura, Naomichi Okamoto, Yuki Konishi, Atsuko Ikenouchi
Clinical Neuropsychopharmacology and Therapeutics, Jul. 2020, Reviewed, No invitation
Last

Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia
Reiji Yoshimura, Atsuko Ikenouchi, Yuki Konishi
Clinical Neuropsychopharmacology and Therapeutics, Jun. 2020, Reviewed, No invitation

Prolonged delirium caused by lithium poisoning in an endometrial cancer patient at advanced stage: A case report.
Natsuyama Tomoya, Okamoto Naomichi, Akaji Haruka, Hoshino Kaori, Ikenouchi Atsuko, Yoshimura Reiji
Clinical case reports, Mar. 2023, Reviewed, No invitation

Hippocampal Sclerosis After Legionnaires' Disease: A Case Report.
Ikenouchi Atsuko, Ide Satoru, Hayasaki Gaku, Adachi Hiroaki, Yoshimura Reiji
Cureus, Dec. 2024, Reviewed, No invitation
Lead, Corresponding

Oromandibular Dystonia After Low-Dose Olanzapine Treatment in a Patient With Marchiafava-Bignami Disease With Demyelinating Lesions in the Corpus Callosum: A Case Report.
Tsukada Nagiho, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko, Yoshimura Reiji
Cureus, Jan. 2024, Null, No invitation

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid.
Okamoto Naomichi, Ikenouchi Atsuko, Seki Issei, Hirano Natsumi, Yoshimura Reiji
Cureus, Jul. 2021, Reviewed, No invitation
Corresponding

Vortioxetine Improved Depressive State In Parkinson's Disease.
Yoshimura Reiji, Ikenouchi Atsuko, Okamoto Naomichi, Konishi Yuki
Cureus, Jun. 2021, Reviewed, No invitation

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram.
Toshida Masamitsu, Konishi Yuki, Ikenouchi Atsuko, Okamoto Naomichi, Yoshimura Reiji
Cureus, May 2021, Reviewed, No invitation

Serum levels of catecholamine metabolites and return to work in patients with major depression: preliminary study.
Yoshimura R, Okamoto N, Konishi Y, Ikenouchi A
The European Journal of Psychiatry, Aug. 2021, Reviewed, No invitation
Last

Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus.
Okamoto Naomichi, Hoshikawa Takashi, Honma Yuichi, Chibaatar Enkhmurun, Ikenouchi Atsuko, Harada Masaru, Yoshimura Reiji
European archives of psychiatry and clinical neuroscience, Nov. 2023, Reviewed, No invitation

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression
Atsuko Ikenouchi, Naomichi Okamoto, Tomomi Matsumoto and Reiji Yoshimura
Frontiers in Psychology, Jun. 2023, Reviewed, No invitation
Lead, Corresponding

Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression.
Tesen Hirofumi, Watanabe Keita, Okamoto Naomichi, Ikenouchi Atsuko, Igata Ryohei, Konishi Yuki, Kakeda Shingo, Yoshimura Reiji
Frontiers in human neuroscience, Jan. 2022, Reviewed, No invitation

Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls.
Fujii Rintaro, Watanabe Keita, Okamoto Naomichi, Natsuyama Tomoya, Tesen Hirofumi, Igata Ryohei, Konishi Yuki, Ikenouchi Atsuko, Kakeda Shingo, Yoshimura Reiji
Frontiers in molecular neuroscience, May 2022, Reviewed, No invitation

Fronto-striato network function is reduced in major depressive disorder.
Kijima Reoto, Watanabe Keita, Okamoto Naomichi, Ikenouchi Atsuko, Tesen Hirofumi, Kakeda Shingo, Yoshimura Reiji
Frontiers in psychiatry, Mar. 2024, Reviewed, No invitation

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder.
Chibaatar Enkhmurun, Watanabe Keita, Okamoto Naomichi, Orkhonselenge Nasanbadrakh, Natsuyama Tomoya, Hayakawa Gaku, Ikenouchi Atsuko, Kakeda Shingo, Yoshimura Reiji
Frontiers in psychiatry, Mar. 2023, Reviewed, No invitation

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms.
Natsuyama Tomoya, Okamoto Naomichi, Watanabe Keita, Chibaatar Enkhmurun, Tesen Hirofumi, Hayasaki Gaku, Ikenouchi Atsuko, Kakeda Shingo, Yoshimura Reiji
Frontiers in psychiatry, Jan. 2023, Reviewed, No invitation

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia.
Okamoto Naomichi, Ikenouchi Atsuko, Watanabe Keita, Igata Ryohei, Fujii Rintaro, Yoshimura Reiji
Frontiers in psychiatry, Dec. 2021, Reviewed, No invitation

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study.
Okamoto Naomichi, Natsuyama Tomoya, Igata Ryohei, Konishi Yuki, Tesen Hirofumi, Ikenouchi Atsuko, Yoshimura Reiji
Frontiers in psychiatry, Jul. 2021, Reviewed, Invited

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings.
Okamoto Naomichi, Yoshino Koji, Kitagawa Shogo, Fujii Rintaro, Hamada Shinsuke, Ikenouchi Atsuko, Konishi Yuki, Ueda Nobuhisa, Eto Yoshinori, Tsutsumi Yasunari, Yoshimura Reiji
Frontiers in psychiatry, Mar. 2021, Reviewed, No invitation

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura Reiji, Hori Hikaru, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Katsuki Asuka, Atake Kiyokazu, Nakamura Jun
Human psychopharmacology, Sep. 2013, Reviewed, Null

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Yoshimura Reiji, Hori Hikaru, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Katsuki Asuka, Hayashi Kenji, Atake Kiyokazu, Tomita Masaru, Nakamura Jun
Human psychopharmacology, Jan. 2012, Reviewed, Null

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Kishi Taro, Umene-Nakano Wakako, Hori Hikaru, Katsuki Asuka, Saito Kazuyoshi, Iwata Nakao, Tanaka Yoshiya, Nakamura Jun
Human psychopharmacology, Jun. 2011, Null, Null

Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology.
Chibaatar Enkhmurun, Fujii Rintarou, Ikenouchi Atsuko, Okamoto Naomichi, Natsuyama Tomoya, Hayasaki Gaku, Shinkai Takahiro, Yoshimura Reiji
International journal of molecular sciences, Dec. 2024, Reviewed, No invitation

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study.
Seki Issei, Izumi Hiroto, Okamoto Naomichi, Ikenouchi Atsuko, Morimoto Yasuo, Horie Seichi, Yoshimura Reiji
International journal of molecular sciences, Sep. 2023, Reviewed, No invitation

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder.
Katsuki Asuka, Watanabe Keita, Nguyen LeHoa, Otsuka Yuka, Igata Ryohei, Ikenouchi Atsuko, Kakeda Shingo, Korogi Yukunori, Yoshimura Reiji
International journal of molecular sciences, Apr. 2020, Reviewed, No invitation

Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report.
Katsumura Tetsuya, Okamoto Naomichi, Tesen Hirofumi, Igata Ryohei, Ikenouchi Atsuko, Yoshimura Reiji
International medical case reports journal, Jul. 2022, Reviewed, No invitation

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine.
Yoshimura Reiji, Ikenouchi Atsuko, Okamoto Naomichi, Konishi Yuki
International medical case reports journal, Apr. 2021, Reviewed, No invitation

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report.
Okamoto Naomichi, Konishi Yuki, Tesen Hirofumi, Ikenouchi Atsuko, Yoshimura Reiji
International medical case reports journal, Apr. 2021, Reviewed, No invitation

Relationship between depressive state and treatment characteristics of acute cervical spinal cord injury in Japan
Matsuda Y, Kubo T, Fujino Y, Matsuda S, Wada F, Sugita A.
Journal of Epidemiology, Nov. 2015, Reviewed, No invitation

Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report
Mako Yanaga, Naomichi Okamoto, Reia Hashimoto, Ryohei Igata, Yuki Konishi, Atsuko Ikenouchi, Naoki Isomoto, Takahiro Shinkai, Masaru Harada, Reiji Yoshimura
Journal of Medical Case Reports, May 2023, Reviewed, No invitation

Protocol for a Survey on the Impact of Caring for a Relative With Dementia on Caregivers' Health and Work Functioning.
Ikenouchi Atsuko, Fujino Yoshihisa, Matsumoto Tomomi, Okamoto Naomichi, Hamada Shinsuke, Kitagawa Shogo, Maruyama Shunya, Konishi Yuki, Eguchi Hisashi, Yoshimura Reiji
Journal of UOEH, Mar. 2025, Reviewed, No invitation
Lead, Corresponding

Volume enlargement of the choroid plexus and brain ventricles in drug-naïve, first-episode major depressive disorder.
Hayasaki Gaku, Chibaatar Enkmurun, Watanabe Keita, Okamoto Naomichi, Quinn Patrick M, Ikenouchi Atsuko, Shinkai Takahiro, Kakeda Shingo, Yoshimura Reiji
Journal of affective disorders, Mar. 2024, Reviewed, No invitation

Triple network connectivity changes in patients with major depressive disorder versus healthy controls via structural network imaging after electroconvulsive therapy treatment
Enkmurun Chibaata, Keita Watanab, Patrick M Quin, Naomichi Okamot, Takahiro Shinkai, Tomoya Natsuyama, Gaku Hayasaki, Atsuko Ikenouchi, Shingo Kakeda, Reiji Yoshimura
Journal of affective disorders, Nov. 2023, Reviewed, No invitation

Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory Study.
Okamoto Naomichi, Hoshikawa Takashi, Ikenouchi Atsuko, Natsuyama Tomoya, Fujii Rintaro, Igata Ryohei, Tesen Hirofumi, Konishi Yuki, Honma Yuichi, Harada Masaru, Yoshimura Reiji
Journal of integrative neuroscience, Jan. 2023, Reviewed, No invitation

The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines.
Ikenouchi Atsuko, Okamoto Naomichi, Igata Ryohei, Natsuyama Tomoya, Yoshimura Reiji
Journal of integrative neuroscience, Jun. 2022, Reviewed, No invitation
Lead, Corresponding

The effects of telecommuting and family cohabiting situation on psychological distress in Japanese workers during the COVID-19 pandemic: A cross-sectional study.
Ikenouchi Atsuko, Fujino Yoshihisa, Matsugaki Ryutaro, Mafune Kosuke, Ando Hajime, Nagata Tomohisa, Tateishi Seiichiro, Yoshimura Reiji, Tsuji Mayumi,
Journal of occupational health, Jan. 2023, Reviewed, No invitation
Lead

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study.
Okamoto Naomichi, Watanabe Keita, Tesen Hirofumi, Ikenouchi Atsuko, Igata Ryohei, Konishi Yuki, Natsuyama Tomoya, Fujii Rintaro, Kakeda Shingo, Kishi Taro, Iwata Nakao, Yoshimura Reiji
Neurology international, Apr. 2022, Reviewed, No invitation

Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in Schizophrenia.
Natsuyama Tomoya, Chibaatar Enkhmurun, Shibata Yuko, Okamoto Naomichi, Cruz Victorino John Noel, Ikenouchi Atsuko, Shibata Tomohiro, Yoshimura Reiji
Neuropsychiatric disease and treatment, Apr. 2025, Reviewed, No invitation

Serum Lipidome Change in Japanese Patients with Major Depressive Disorder: A Real-World Exploratory Study.
Okamoto Naomichi, Fujii Rintaro, Chibaatar Enkhmurun, Iino Chihiro, Ikenouchi Atsuko, Yoshimura Reiji
Neuropsychiatric disease and treatment, Aug. 2025, Reviewed, No invitation

Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study.
Ikenouchi Atsuko, Konno Yusuke, Fujino Yoshihisa, Adachi Naoto, Kubota Yukihisa, Azekawa Takaharu, Ueda Hitoshi, Edagawa Koji, Katsumoto Eiichi, Goto Eiichiro, Hongo Seiji, Kato Masaki, Tsuboi Takashi, Yasui-Furukori Norio, Nakagawa Atsuo, Kikuchi Toshiaki, Watanabe Koichiro, Yoshimura Reiji
Neuropsychiatric disease and treatment, Apr. 2022, Reviewed, No invitation
Lead

Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation.
Hoshikawa Takashi, Okamoto Naomichi, Natsuyama Tomoya, Fujii Rintaro, Ikenouchi Atsuko, Honma Yuichi, Harada Masaru, Yoshimura Reiji
Neuropsychiatric disease and treatment, Jan. 2022, Reviewed, No invitation

Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project.
Konno Yusuke, Fujino Yoshihisa, Ikenouchi Atsuko, Adachi Naoto, Kubota Yukihisa, Azekawa Takaharu, Ueda Hitoshi, Edagawa Koji, Katsumoto Eiichi, Goto Eiichiro, Hongo Seiji, Kato Masaki, Tsuboi Takashi, Yasui-Furukori Norio, Nakagawa Atsuo, Kikuchi Toshiaki, Watanabe Koichiro, Yoshimura Reiji
Neuropsychiatric disease and treatment, Sep. 2021, Reviewed, No invitation

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study.
Okamoto Naomichi, Watanabe Keita, Ngyuyen LeHoa, Ikenouchi Atsuko, Kishi Taro, Iwata Nakao, Kakeda Shingo, Korogi Yukunori, Yoshimura Reiji
Neuropsychiatric disease and treatment, Oct. 2020, Reviewed, No invitation

Risk Factors in Japanese Drug Overdose Patients: Identifying Their Associations With Suicide Risk
Naomichi Okamoto, Atsuko Ikenouchi, Enkhmurun Chibaatar, Keita Watanabe, Ryohei Igata, Issei Seki, Reiji Yoshimura
OMEGA Journal of Death and Dying, Mar. 2023, Reviewed, No invitation
Corresponding

Serum fetuin-A in major depressive disorder: Lower levels in patients, but no correlation with symptom severity.
Ikenouchi Atsuko, Fujii Rintaro, Yoshimura Reiji
PCN reports : psychiatry and clinical neurosciences, Sep. 2025, Reviewed, No invitation
Lead, Corresponding

The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains.
Ueda Issei, Takemoto Kazuhiro, Watanabe Keita, Sugimoto Koichiro, Ikenouchi Atsuko, Kakeda Shingo, Katsuki Asuka, Yoshimura Reiji, Korogi Yukunori
PeerJ, Jul. 2020, Reviewed, No invitation

A CASE OF PERSISTENT DEPRESSIVE DISORDER WITH A SIGNIFICANT RESPONSE TO THE ADDITION OF LURASIDONE TO VORTIOXETINE.
Yoshimura Reiji, Okamoto Naomichi, Hamada Shinsuke, Ikenouchi Atsuko
Psychiatria Danubina, Aug. 2023, Reviewed, No invitation
Last

Duloxetine Does not Affect Vascular Endothelial Growth Factor Plasma Levels in Patients with First-Episode, Drug-Naïve Major Depression
Reiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatria Danubina, Mar. 2023, Reviewed, No invitation
Last

Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major Depression.
Yoshimura Reiji, Okamoto Naomichi, Ikenouchi Atsuko
Psychiatria Danubina, Oct. 2022, Reviewed, No invitation
Last

Differences in the Disease Severity and Background Characteristics of Patients with Suicide Attempts Due to Overdose According to the Time of Day.
Hirashima Tatsuro, Okamoto Naomichi, Ikenouchi Atsuko, Mayumi Toshihiko, Yoshimura Reiji
Psychiatria Danubina, Jul. 2022, Reviewed, No invitation

L-Arginine-Nitric Oxide Pathway and Neural Networks in Major Depression.
Okamoto Naomichi, Watanabe Keita, Ikenouchi Atsuko, Korogi Yukinori, Yoshimura Reiji
Psychiatria Danubina, Apr. 2022, Reviewed, No invitation

Isolated Adrenocorticotropic Hormone Deficiency accompanied by impaired cognitive function: A case report
Atsuko Ikenouchi, Issei Seki, Naomichi Okamoto, Yuki Konishi, Reiji Yoshimura
Psychiatry Research Case Reports, Sep. 2022, Reviewed, No invitation
Lead, Corresponding

Human immunodeficiency virus-related neurocognitive disorder with _x000D_ hallucinations and delusions: A case report
Junpei Igata, Naomichi Okamoto, Hirofumi Tesen, Maya Akiyama, Satoru Ide, Atsuko Ikenouchi, Reiji Yoshimura
Psychiatry Research Case Reports, Nov. 2023, Reviewed, No invitation

Human immunodeficiency virus-related neurocognitive disorder with hallucinations and delusions: A case report
Junpei Igata, Naomichi Okamoto, Hirofumi Tesen, Maya Akiyama, Satoru Ide, Atsuko Ikenouchi, Reiji Yoshimura
Psychiatry Research Case Reports, Jun. 2024, Reviewed, Null

A case of 10-year retrograde amnesia, cognitive dysfunction, and hippocampal atrophy after limbic encephalitis associated with rickettsiosis
Naomichi Okamoto,Atsuko Ikenouchi,Shoichi Shimizu,Satoru Ide,Enkhmurun Chibaatar,Reiji Yoshimura
Psychiatry Research Case Reports, Dec. 2023, Reviewed, No invitation

Comparison of plasma catecholamine metabolites in melancholic and non-melancholic depression
Reiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatry Research Communications, Jun. 2022, Reviewed, No invitation
Last

No interaction between plasma IL-6 and MHPG in major depression treated with paroxetine
Reiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatry Research Communications, Sep. 2022, Reviewed, No invitation
Last

Effect of risperidone on plasma vascular endothelial growth factor levels in _x000D_ patients with first-episode schizophrenia: A preliminary study
Reiji Yoshimura, Naomichi Okamoto, Gaku Hayasaki, Issei Seki, Reoto Kijima, Enkmurun Chibaatar, Atsuko Ikenouchi
Psychiatry Research Communications, Dec. 2023, Reviewed, No invitation
Last

Whole-brain structural covariance network abnormality in first-episode and drug-naïve major depressive disorder.
Watanabe Keita, Kakeda Shingo, Katsuki Asuka, Ueda Issei, Ikenouchi Atsuko, Yoshimura Reiji, Korogi Yukunori
Psychiatry research. Neuroimaging, Jun. 2020, Reviewed, No invitation

Auditory hallucinations of Buddhist chanting as an initial symptom of mild cognitive impairment with Lewy bodies
Naomichi Okamot, Atsuko Ikenouchi, Tatsuro Hirashima, Hirofumi Tesen, Satoru Ide, Reiji Yoshimura
Psychogeriatrics, Jul. 2023, Reviewed, No invitation

A male case of frontotemporal lobar degeneration with behavioural and psychiatric symptoms responding to a low dose of escitalopram.
Ikenouchi Atsuko, Seki Issei, Takaoka Kei, Okamoto Naomichi, Murakami Sayuri, Yoshimura Reiji
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Feb. 2021, Reviewed, No invitation
Lead, Corresponding

Low-dose lamotrigine induces Pisa syndrome in a patient with probable corticobasal degeneration despite previous use.
Okamoto Naomichi, Sakakibara Takahiro, Tsukada Nagiho, Chibaatar Enkhmurun, Hayasaki Gaku, Konishi Yuki, Ikenouchi Atsuko, Yoshimura Reiji
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Nov. 2024, Reviewed, No invitation

Cerebellar cognitive affective syndrome caused by cerebellar atrophy associated with Wallerian degeneration after pontine haemorrhage: a case report.
Ikenouchi Atsuko, Ide Satoru, Hamada Shinsuke, Yoshimura Reiji
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Sep. 2024, Reviewed, No invitation
Lead, Corresponding

A case of folate deficiency showing behavioural variant of frontotemporal dementia-like symptoms.
Fujii Arisa, Ikenouchi Atsuko, Okamoto Naomichi, Fujii Rintaro, Ide Satoru, Yoshimura Reiji
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Mar. 2024, Reviewed, No invitation
Corresponding

A case of exploding head syndrome preceding the onset of mild cognitive impairment with Lewy bodies.
Kitagawa Shogo, Okamoto Naomichi, Ikenouchi Atsuko, Igata Ryohei, Hashimoto Reia, Konishi Yuki, Tesen Hirofumi, Yoshimura Reiji
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Jan. 2023, Reviewed, No invitation

Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression.
Yoshimura Reiji, Ikenouchi Atsuko, Okamoto Naomichi
Psychopharmacology bulletin, Oct. 2022, Reviewed, No invitation
Last

Vortioxetine improved olfactory reference syndrome in a patient with major depressive disorder: A case report.
Yoshimura R, Konishi Y, Okamoto N, Ikenouchi A
Revista de Psiquiatria Clinica, Jul. 2021, Reviewed, No invitation
Last

Plasma paroxetine level is independent of the change in plasma interleukin-6 level in remitted patients with major depressive disorder.
Yoshimura R, Okamoto N, Konishi Y, Ikenouchi A
Revista de Psiquiatria Clinica, Jul. 2021, Reviewed, No invitation
Last

Reduced homovanillic acid, SDF-1α, and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
Yuya Fujita, Shigeru Iwata, Shinsuke Hidese, Sayuri Ishiwata, Satoru Ide, Hiroaki Tanaka, Koshiro Sonomoto, Yusuke Miyazaki, Shingo Nakayamada, Atsuko Ikenouchi, Kotaro Hattori, Hiroshi Kunugi, Reiji Yoshimura, Yoshiya Tanaka
Rheumatology (Oxford, England), Feb. 2023, Reviewed, No invitation

Oral Cenesthopathy Proceeding Dementia with Lewy Body: a Case Report
Yuta Sawada, Yuki Konishi, Atsuko Ikenouchi, Reiji Yoshimura1
SN Comprehensive Clinical Medicine, Feb. 2021, Reviewed, No invitation

Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
Igata Ryohei, Tesen Hirofumi, Konishi Yuki, Ikenouchi Atsuko, Okamoto Naomichi, Yoshimura Reiji
Schizophrenia research, Jul. 2021, Reviewed, No invitation

Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study.
Nguyen LeHoa, Kakeda Shingo, Watanabe Keita, Katsuki Asuka, Sugimoto Koichiro, Igata Natsuki, Shinkai Takahiro, Abe Osamu, Korogi Yukunori, Ikenouchi Atsuko, Yoshimura Reiji
Scientific reports, Dec. 2020, Reviewed, No invitation

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
Reiji Yoshimura, Naomichi Okamoto, Yuki Konishi and Atsuko Ikenouchi
Therapeutic Advances in Psychopharmacology, May 2021, Reviewed, No invitation
Last

Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder.
Yoshimura Reiji, Hori Hikaru, Umene-Nakano Wakako, Ikenouchi-Sugita Atsuko, Katsuki Asuka, Atake Kiyokazu, Nakamura Jun
Therapeutic advances in psychopharmacology, Jun. 2014, Null, Null

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression.
Yoshimura Reiji, Okamoto Naomichi, Ikenouchi Atsuko
Therapeutic advances in psychopharmacology, Aug. 2022, Reviewed, No invitation
Last

Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study.
Okamoto Naomichi, Hoshikawa Takashi, Ikenouchi Atsuko, Yoshimura Reiji
Therapeutic advances in psychopharmacology, Nov. 2021, Reviewed, No invitation

Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Okamoto Tatsuya, Umene-Nakano Wakako, Ueda Nobuhisa, Hori Hikaru, Katsuki Asuka, Saito Kazuyoshi, Tanaka Yoshiya, Nakamura Jun
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Mar. 2010, Null, Null
Lead

Influence of Th2 cells on hair cycle/growth after repeated cutaneous application of hapten.
Sugita K, Nomura T, Ikenouchi-Sugita A, Ito T, Nakamura M, Miyachi Y, Tokura Y, Kabashima K
Clinical and experimental dermatology, Mar. 2014, Null, Null

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder.
Atake Kiyokazu, Yoshimura Reiji, Hori Hikaru, Katsuki Asuka, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Nakamura Jun
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2014, Null, Null

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.
Tokutsu Yuki, Umene-Nakano Wakako, Shinkai Takahiro, Yoshimura Reiji, Okamoto Tatsuya, Katsuki Asuka, Hori Hikaru, Ikenouchi-Sugita Atsuko, Hayashi Kenji, Atake Kiyokazu, Nakamura Jun
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2013, Null, Null

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients.
Yoshimura Reiji, Kishi Taro, Hori Hikaru, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Katsuki Asuka, Hayashi Kenji, Iwata Nakao, Nakamura Jun
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, Apr. 2012, Null, Null

Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls.
Goto N, Yoshimura R, Kakeda S, Moriya J, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Hori H, Ueda N, Korogi Y, Nakamura J
European psychiatry : the journal of the Association of European Psychiatrists, Jan. 2011, Null, Null

Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Hori Hikaru, Umene-Nakano Wakako, Katsuki Asuka, Saito Kazuyoshi, Tanaka Yoshiya, Nakamura Jun
Human psychopharmacology, Mar. 2013, Null, Null
Lead

Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Kishi Taro, Umene-Nakano Wakako, Hori Hikaru, Hayashi Kenji, Katsuki Asuka, Ueda Nobuhisa, Iwata Nakao, Nakamura Jun
Human psychopharmacology, Oct. 2011, Null, Null
Lead

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Kishi Taro, Umene-Nakano Wakako, Hori Hikaru, Katsuki Asuka, Saito Kazuyoshi, Iwata Nakao, Tanaka Yoshiya, Nakamura Jun
Human psychopharmacology, Null, Null

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Kishi Taro, Umene-Nakano Wakako, Hori Hikaru, Katsuki Asuka, Saito Kazuyoshi, Iwata Nakao, Tanaka Yoshiya, Nakamura Jun
Human psychopharmacology, Null, Null

Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.
Yoshimura Reiji, Umene-Nakano Wakako, Hoshuyama Tsutomu, Ikenouchi-Sugita Atsuko, Hori Hikaru, Katsuki Asuka, Hayashi Kenji, Atake Kiyokazu, Nakamura Jun
Human psychopharmacology, Nov. 2010, Null, Null

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations.
Yoshimura Reiji, Umene-Nakano Wakako, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Hori Hikaru, Katsuki Asuka, Hayashi Kenji, Miyamoto Kyoko, Kodama Yuki, Nakamura Jun
Human psychopharmacology, Aug. 2010, Null, Null

Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Umene-Nakano Wakako, Yoshimura Reiji, Yoshii Chiharu, Hoshuyama Tsutomu, Hayashi Kenji, Hori Hikaru, Katsuki Asuka, Ikenouchi-Sugita Atsuko, Nakamura Jun
Human psychopharmacology, Apr. 2010, Null, Null

Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study.
Nakano Yuichiro, Yoshimura Reiji, Nakano Hideki, Ikenouchi-Sugita Atsuko, Hori Hikaru, Umene-Nakano Wakako, Ueda Nobuhisa, Nakamura Jun
Human psychopharmacology, Mar. 2010, Null, Null

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
Goto Naoki, Yoshimura Reiji, Kakeda Shingo, Moriya Junji, Hayashi Kenji, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Hori Hikaru, Ueda Nobuhisa, Korogi Yukunori, Nakamura Jun
Human psychopharmacology, Dec. 2009, Null, Null

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.
Yoshimura Reiji, Umene-Nakano Wakako, Suzuki Akihito, Ueda Nobuhisa, Miyamoto Kyoko, Ikenouchi-Sugita Atsuko, Hori Hikaru, Otani Koichi, Nakamura Jun
Human psychopharmacology, Aug. 2009, Null, Null

Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.
Umene-Nakano Wakako, Yoshimura Reiji, Ikenouchi-Sugita Atsuko, Hori Hikaru, Hayashi Kenji, Ueda Nobuhisa, Nakamura Jun
Human psychopharmacology, Jul. 2009, Null, Null

Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.
Yoshimura Reiji, Umene-Nakano Wakako, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Hori Hikaru, Nakamura Jun
Human psychopharmacology, Dec. 2008, Null, Null

Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.
Hori Hikaru, Yoshimura Reiji, Katsuki Asuka, Hayashi Kenji, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Nakamura Jun
International journal of psychiatry in clinical practice, Jun. 2012, Null, Null

The effects of a walking intervention on depressive feelings and social adaptation in healthy workers.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Sugita Kazunari, Hori Hikaru, Yamada Kumi, Sakaue Mayumi, Nakamura Jun
Journal of UOEH, Mar. 2013, Null, Null
Lead

Erythema annulare centrifugum associated with herpes zoster.
Ohmori Shun, Sugita Kazunari, Ikenouchi-Sugita Atsuko, Nakamura Motonobu
Journal of UOEH, Sep. 2012, Null, Null

Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels.
Yoshimura Reiji, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Hori Hikaru, Ueda Nobuhisa, Nakamura Jun
Journal of clinical psychopharmacology, Feb. 2010, Null, Null

Survey of nasal colonization by, and assessment of a novel multiplex PCR method for detection of biofilm-forming methicillin-resistant staphylococci in healthy medical students.
Miyamoto H, Imamura K, Kojima A, Takenaka H, Hara N, Ikenouchi A, Tanabe T, Taniguchi H
The Journal of hospital infection, Mar. 2003, Null, Null

Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival.
Sugita Kazunari, Kabashima Kenji, Yoshiki Ryutaro, Ikenouchi-Sugita Atsuko, Tsutsui Masato, Nakamura Jun, Yanagihara Nobuyuki, Tokura Yoshiki
The Journal of investigative dermatology, Feb. 2010, Null, Null

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
Hori Hikaru, Yoshimura Reiji, Katsuki Asuka, Hayashi Kenji, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Nakamura Jun
Journal of psychiatric research, Jun. 2012, Null, Null

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
Umene-Nakano Wakako, Yoshimura Reiji, Ueda Nobuhisa, Suzuki Akihito, Ikenouchi-Sugita Atsuko, Hori Hikaru, Otani Koichi, Nakamura Jun
Journal of psychopharmacology (Oxford, England), Dec. 2010, Null, Null

Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex.
Ikenouchi-Sugita Atsuko, Toyohira Yumiko, Yoshimura Reiji, Ueno Susumu, Tsutsui Masato, Nakamura Jun, Yanagihara Nobuyuki
Naunyn-Schmiedeberg's archives of pharmacology, Dec. 2009, Null, Null
Lead

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.
Goto Naoki, Yoshimura Reiji, Kakeda Shingo, Nishimura Joji, Moriya Junji, Hayashi Kenji, Katsuki Asuka, Hori Hikaru, Umene-Nakano Wakako, Ikenouchi-Sugita Atsuko, Korogi Yukunori, Nakamura Jun
Neuropsychiatric disease and treatment, Jun. 2012, Null, Null

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Ueda Nobuhisa, Kodama Yuki, Umene-Nakano Wakako, Nakamura Jun
Neuropsychiatric disease and treatment, Dec. 2008, Null, Null
Lead

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study.
Hayashi Kenji, Yoshimura Reiji, Kakeda Shingo, Kishi Taro, Abe Osamu, Umene-Nakano Wakako, Katsuki Asuka, Hori Hikaru, Ikenouchi-Sugita Atsuko, Watanabe Keita, Ide Satoru, Ueda Issei, Moriya Junji, Iwata Nakao, Korogi Yukunori, Kubicki Marek, Nakamura Jun
Neuropsychiatric disease and treatment, Jun. 2014, Null, Null

Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Umene-Nakano Wakako, Yoshimura Reiji, Yoshii Chiharu, Hayashi Kenji, Ikenouchi-Sugita Atsuko, Katsuki Asuka, Hori Hikaru, Nakamura Jun
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, Apr. 2012, Null, Null

[Niacin deficiency and cutaneous immunity].
Ikenouchi-Sugita Atsuko, Sugita Kazunari
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, Dec. 2014, Null, Null
Lead

[Review of pharmacological efficacies and side effects of antidepressants].
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Nakamura Jun
Nihon rinsho. Japanese journal of clinical medicine, Sep. 2007, Null, Null
Lead

[Brain-derived neurotrophic factor (BDNF) and mood disorder].
Yoshimura Reiji, Ikenouchi-Sugita Atsuko, Hori Hikaru, Umene-Nakano Wakako, Katsuki Asuka, Hayashi Kenji, Atake Kiyokazu, Ueda Nobuhisa, Nakamura Jun
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, Nov. 2010, Null, Null

A male case of monosymptomatic hypochondriacal psychosis responding to olanzapine: a case report.
Ikenouchi A, Terao T, Nakamura J
Pharmacopsychiatry, Sep. 2004, Null, Null
Lead

Abnormal white matter integrity in the corpus callosum among smokers: tract-based spatial statistics.
Umene-Nakano Wakako, Yoshimura Reiji, Kakeda Shingo, Watanabe Keita, Hayashi Kenji, Nishimura Joji, Takahashi Hidehiko, Moriya Junji, Ide Satoru, Ueda Issei, Hori Hikaru, Ikenouchi-Sugita Atsuko, Katsuki Asuka, Atake Kiyokazu, Abe Osamu, Korogi Yukunori, Nakamura Jun
PloS one, Jun. 2014, Null, Null

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Yoshimura Reiji, Kishi Taro, Hori Hikaru, Ikenouchi-Sugita Atsuko, Katsuki Asuka, Umene-Nakano Wakako, Iwata Nakao, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Dec. 2012, Null, Null

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
Yoshimura Reiji, Kishi Taro, Suzuki Akihito, Umene-Nakano Wakako, Ikenouchi-Sugita Atsuko, Hori Hikaru, Otani Koichi, Iwata Nakao, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Jun. 2011, Null, Null

No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia.
Goto Naoki, Yoshimura Reiji, Kakeda Shingo, Moriya Junji, Hori Hikaru, Hayashi Kenji, Ikenouchi-Sugita Atsuko, Nakano-Umene Wakako, Katsuki Asuka, Nishimura Joji, Korogi Yukunori, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Dec. 2010, Null, Null

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
Yoshimura Reiji, Ikenouchi-Sugita Atsuko, Hori Hikaru, Umene-Nakano Wakako, Katsuki Asuka, Hayashi Kenji, Ueda Nobuhisa, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Mar. 2010, Null, Null

Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Hori Hikaru, Umene-Nakano Wakako, Ueda Nobuhisa, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Nov. 2009, Null, Null
Lead

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.
Yoshimura Reiji, Hori Hikaru, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Ueda Nobuhisa, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Jun. 2009, Null, Null

Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
Okamoto Tatsuya, Yoshimura Reiji, Ikenouchi-Sugita Atsuko, Hori Hikaru, Umene-Nakano Wakako, Inoue Yoshiaki, Ueda Nobuhisa, Nakamura Jun
Progress in neuro-psychopharmacology & biological psychiatry, Jul. 2008, Null, Null

PATIENT WITH PARKINSON'S DISEASE AND DEPRESSIVE SYMPTOMS ASSOCIATED WITH IMPULSE CONTROL DISORDER.
Migita Kanae, Okamoto Naomichi, Ikenouchi Atsuko, Kijima Reoto, Hashimoto Tomoyo, Adachi Hiroaki, Yoshimura Reiji
Psychiatria Danubina, May 2024, Reviewed, No invitation

Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self-evaluation Scale as calibrated using the Beck Depression Inventory.
Ueda Nobuhisa, Suda Akira, Nakagawa Makiko, Nakano Hideki, Umene-Nakano Wakako, Ikenouchi-Sugita Atsuko, Hori Hikaru, Yoshimura Reiji, Nakamura Jun
Psychiatry and clinical neurosciences, Dec. 2011, Null, Null

Trichotilliomania responding to low-dose fluvoxamine.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Ueda Nobuhisa, Nakamura Jun
Psychiatry and clinical neurosciences, Oct. 2009, Null, Null
Lead

Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Hori Hikaru, Ueda Nobuhisa, Nakamura Jun
Psychiatry and clinical neurosciences, Aug. 2007, Null, Null
Lead

No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.
Kishi Taro, Fukuo Yasuhisa, Moriwaki Masatsugu, Iwata Nakao, Hori Hikaru, Yoshimura Reiji, Katsuki Asuka, Ikenouchi-Sugita Atsuko, Atake Kiyokazu, Umene-Nakano Wakako, Nakamura Jun, Kaneda Yasuhiro, Fujita Kiyoshi
Psychiatry research, Mar. 2014, Null, Null

Current smoking rate in patients with psychiatric disorders in Japan: questionnaire survey.
Umene-Nakano Wakako, Yoshimura Reiji, Hoshuyama Tsutomu, Yoshii Chiharu, Hayashi Kenji, Nakano Hideki, Hori Hikaru, Ikenouchi-Sugita Atsuko, Katsuki Asuka, Atake Kiyokazu, Nakamura Jun
Psychiatry research, Nov. 2013, Null, Null

Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan.
Okuno Kanae, Yoshimura Reiji, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Hori Hikaru, Hayashi Kenji, Katsuki Asuka, Chen Hsin-I, Nakamura Jun
Psychiatry research, Apr. 2011, Null, Null

Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study.
Goto Naoki, Yoshimura Reiji, Moriya Junji, Kakeda Shingo, Hayashi Kenji, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Oonari Norihiro, Korogi Yukunori, Nakamura Jun
Psychiatry research, Apr. 2010, Null, Null

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.
Goto Naoki, Yoshimura Reiji, Moriya Junji, Kakeda Shingo, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Hayashi Kenji, Oonari Norihiro, Korogi Yukunori, Nakamura Jun
Schizophrenia research, Jul. 2009, Null, Null

Prostaglandin E₂ is critical for the development of niacin-deficiency-induced photosensitivity via ROS production.
Sugita Kazunari, Ikenouchi-Sugita Atsuko, Nakayama Yasuko, Yoshioka Haruna, Nomura Takashi, Sakabe Jun-Ichi, Nakahigashi Kyoko, Kuroda Etsushi, Uematsu Satoshi, Nakamura Jun, Akira Shizuo, Nakamura Motonobu, Narumiya Shuh, Miyachi Yoshiki, Tokura Yoshiki, Kabashima Kenji
Scientific reports, Oct. 2013, Null, Null

[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].
Yoshimura Reiji, Ikenouchi-Sugita Atsuko, Hori Hikaru, Umene-Nakano Wakako, Hayashi Kenji, Katsuki Asuka, Ueda Nobuhisa, Nakamura Jun
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, Jun. 2010, Null, Null

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Yoshimura Reiji, Ueda Nobuhisa, Hori Hikaru, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Nakamura Jun
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Mar. 2010, Null, Null

A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).
Ikenouchi-Sugita Atsuko, Yoshimura Reiji, Hayashi Kenji, Ueda Nobuhisa, Umene-Nakano Wakako, Hori Hikaru, Nakamura Jun
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Jun. 2009, Null, Null
Lead

Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers.
Ueda Nobuhisa, Yoshimura Reiji, Umene-Nakano Wakako, Ikenouchi-Sugita Atsuko, Hori Hikaru, Hayashi Kenji, Kodama Yuki, Nakamura Jun
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Jun. 2009, Null, Null

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
Hori Hikaru, Yoshimura Reiji, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Nakamura Jun
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Jun. 2009, Null, Null

産業保健ストラテジーシリーズ = Strategy for occupational health services ; 第5巻 適正配置・両立支援ストラテジー 3.17認知症と適正配置
遠田和彦; 監修; 神奈川芳行; 編集長; 河津雄一郎; 永田昌子; 副編集長, Contributor, 295-307
バイオコミュニケーションズ, Jan. 2026
9784901686846

Ⅰ臨床薬理学総論　Ⅰ-2　薬物療法と社会
池ノ内篤子, 吉村玲児, Contributor
星和書店, Mar. 2021
9784791110742